651 related articles for article (PubMed ID: 11745674)
21. Loss of heterozygosity in epithelial cells obtained by bronchial brushing: clinical utility in lung cancer.
Powell CA; Klares S; O'Connor G; Brody JS
Clin Cancer Res; 1999 Aug; 5(8):2025-34. PubMed ID: 10473082
[TBL] [Abstract][Full Text] [Related]
22. Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma.
Obermann EC; Diss TC; Hamoudi RA; Munson P; Wilkins BS; Camozzi ML; Isaacson PG; Du MQ; Dogan A
J Pathol; 2004 Feb; 202(2):252-62. PubMed ID: 14743509
[TBL] [Abstract][Full Text] [Related]
23. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
Nishisaka T; Takeshima Y; Inai K
Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
[TBL] [Abstract][Full Text] [Related]
25. Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma.
Varella-Garcia M; Gemmill RM; Rabenhorst SH; Lotto A; Drabkin HA; Archer PA; Franklin WA
Cancer Res; 1998 Oct; 58(20):4701-7. PubMed ID: 9788625
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic value of heterozygosity loss in chromosome 3p in non-microcytic bronchogenic carcinoma].
Maestro ML; Izquierdo L; Sánchez-Pernaute A; Sanz Casla MT; González S; Torres A; del Barco V; Gómez A; Pérez Aguirre E; Balibrea JL
Med Clin (Barc); 1999 Apr; 112(14):527-9. PubMed ID: 10363238
[TBL] [Abstract][Full Text] [Related]
27. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer.
Neville EM; Stewart M; Myskow M; Donnelly RJ; Field JK
Oncogene; 1995 Aug; 11(3):581-5. PubMed ID: 7630642
[TBL] [Abstract][Full Text] [Related]
29. Molecular genetic changes associated with ovarian cancer.
Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
[TBL] [Abstract][Full Text] [Related]
30. p53 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma.
Kohno H; Hiroshima K; Toyozaki T; Fujisawa T; Ohwada H
Cancer; 1999 Jan; 85(2):341-7. PubMed ID: 10023701
[TBL] [Abstract][Full Text] [Related]
31. Microsatellite instability and loss of heterozygosity at the hMLH1 locus on chromosome 3p21 occur in a subset of nonsmall cell lung carcinomas.
Wieland I; Ammermüller T; Böhm M; Totzeck B; Rajewsky MF
Oncol Res; 1996; 8(1):1-5. PubMed ID: 8704281
[TBL] [Abstract][Full Text] [Related]
32. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
[TBL] [Abstract][Full Text] [Related]
33. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
Xu XF; Gao YN; Cheng SJ
Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma.
Tomizawa Y; Adachi J; Kohno T; Hamada K; Saito R; Noguchi M; Matsuno Y; Hirohashi S; Yamaguchi N; Yokota J
Clin Cancer Res; 1999 May; 5(5):1139-46. PubMed ID: 10353749
[TBL] [Abstract][Full Text] [Related]
35. Multitarget FISH and LOH analyses at chromosome 3p in non-small cell lung cancer and adjacent bronchial epithelium.
Woenckhaus M; Grepmeier U; Wild PJ; Merk J; Pfeifer M; Woenckhaus U; Stoelcker B; Blaszyk H; Hofstaedter F; Dietmaier W; Hartmann A
Am J Clin Pathol; 2005 May; 123(5):752-61. PubMed ID: 15981815
[TBL] [Abstract][Full Text] [Related]
36. [Distinguishing second primary tumors from lung metastasis in patients with postoperative non-small cell lung cancer by microsatellite analysis].
Wang J; Lu C; Liu XY; Zhang HB; Zhao J; Yang L; Guo QZ; An TT; Wu MN
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):103-7. PubMed ID: 17445470
[TBL] [Abstract][Full Text] [Related]
37. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
Rosin MP; Cheng X; Poh C; Lam WL; Huang Y; Lovas J; Berean K; Epstein JB; Priddy R; Le ND; Zhang L
Clin Cancer Res; 2000 Feb; 6(2):357-62. PubMed ID: 10690511
[TBL] [Abstract][Full Text] [Related]
38. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.
Shiseki M; Kohno T; Nishikawa R; Sameshima Y; Mizoguchi H; Yokota J
Cancer Res; 1994 Nov; 54(21):5643-8. PubMed ID: 7923210
[TBL] [Abstract][Full Text] [Related]
39. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C
Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133
[TBL] [Abstract][Full Text] [Related]
40. High rate of molecular alteration in histologically tumour-free bronchial epithelium of NSCLC patients detected by multicolour fluorescence in situ hybridisation.
Hilbe W; Auberger J; Dirnhofer S; Schmid T; Erdel M; Duba HC
Oncol Rep; 2006 May; 15(5):1233-40. PubMed ID: 16596192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]